Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarcinoma. This evidence concerns the gene GALNT5 and pancreatic ductal adenocarcinoma.